Oriola Oyj (HEL: OKDBV)

Market Cap	168.78M
Revenue (ttm)	1.63B
Net Income (ttm)	-5.10M
Shares Out	181.41M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	12.24
Dividend	0.07 (7.54%)
Ex-Dividend Date	Mar 20, 2024

Volume	66,045
Average Volume	151,276
Open	0.934
Previous Close	0.928
Day's Range	0.929 - 0.938
52-Week Range	0.850 - 1.136
Beta	0.61
RSI	54.12
Earnings Date	Mar 4, 2025

About Oriola Oyj

Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed medicines; and provision of advisory services. The company serves pharmaceutical companies, pharmacies, veterinarians, and hospitals. Oriola Oyj was i...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2006
• Employees: 895
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: OKDBV

Financial Performance

In 2023, Oriola Oyj's revenue was 1.50 billion, a decrease of -2.90% compared to the previous year's 1.54 billion. Losses were -20.70 million, 762.5% more than in 2022.